Basic info
Industry
biotechnology research
Sectors
Biotechnology
EVICTIONtrial
adaptative immunity
gamma-deltaTcells
precision-based medicine
oncology
Immune checkpoint Modulators
Health Care
innate immunity
Auto-immunity
Therapeutics
cancer
immuno-oncology
antibodies
Biopharma
Life Science
ICT01
Date founded
2015
Funding rounds raised
Total raised
$100M
from 17 investors over 17 rounds
I
Imcheck Therapeutics raised $100M on June 13, 2022
Investors: Pureos Bioventures, Gimv, The Invus Group, Earlybird Venture Capital, Eurazeo, The Leukemia & Lymphoma Society, Wellington Partners and EQT Life Sciences
I
Imcheck Therapeutics raised $7.1M on September 15, 2020
Investors: Pureos Bioventures
I
Imcheck Therapeutics raised $53M on December 4, 2019
Investors: Kinled Holding Ltd, Gimv, Wellington Partners, EQT Life Sciences and Idinvest Partners
I
Imcheck Therapeutics raised $22M on May 2, 2017
Investors: Gimv, Idinvest Partners and EQT Life Sciences